A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)

Recruiting now · Not applicable

Conditions studied: Renal Tumor, Renal Cancer

In brief

The goal of this clinical trial is to evaluate peri and post-operative outcomes as well as long-term survival of 3D IGRAPN compared to conventional Robot-Assisted Partial Nephrectomy (RAPN) for moderate and highly complex renal tumors. The main questions aim to answer: * peri-operative complications * oncological safety * long term renal function Participants will be asked to do undergo 3D-IGRAPN. Researchers will compare 3D-IGRAPN to RAPN to see if peri-operative outcomes are better in the experimental group.

Key facts

Study ID

NCT05572216

Run by

University Hospital, Grenoble

People needed

694

Starts

2023-01-24

Expected to finish

2027-11-01

Last updated by the study team

2024-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients over 18 years
• Indication of RAPN for suspicious renal tumor
• Moderate or high complexity renal tumor (RENAL Nephrometry Score (NS) >7)
• Da Vinci® surgical system available for the surgery
• Patient affiliated to the French social security system or an equivalent system
• Signed informed consent form UroCCR and ACCURATE

You may not qualify if…

• Medical contraindication to RAPN
• Renal insufficiency forbidding iodine injection
• Patient with allergy to iodinated contrast products
• Patient concerned by articles L1121-5 to 8 of the French public health code (protected persons)

Where it is running

• University Hospital Grenoble — Grenoble, France (enrolling)
• university HospitalGrenoble — Grenoble, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.